StockData
Becton Dickinson & Co logo

Becton Dickinson & Co (BDX) stock

BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 13/3015% above fair value
$215.71+1.19 (+0.55%)

Close on Nov 12, 2026Market cap $58.76BP/E 65.2Yield 1.93%

Becton Dickinson EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Becton Dickinson's EV/EBITDA was 15.3× on Nov 10, 2026, against 14.8× a year earlier. Over the last 5 years it ranged from 11.5× to 22.3×, with a median of 19.0×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 10, 202615.3×+0.5
2025Dec 31, 202514.8×−3.2
2024Dec 31, 202418.0×−1.2
2023Dec 29, 202319.3×−0.2
2022Dec 30, 202219.5×−0.3
2021Dec 31, 202119.8×−8.5
2020Dec 31, 202028.3×+5.0
2019Dec 31, 201923.3×+0.4
2018Dec 31, 201822.9×+2.8
2017Dec 29, 201720.1×+2.0
2016Dec 30, 201618.1×−4.0
2015Dec 31, 201522.1×+8.4
2014Dec 31, 201413.7×+0.3
2013Dec 31, 201313.4×+4.3
2012Dec 31, 20129.1×+0.6
2011Dec 30, 20118.5×−1.5
2010Dec 31, 201010.0×+0.3
2009Dec 31, 20099.7×–

More Becton Dickinson figures

See a number that looks wrong?